The startup using AI to help rare disease families develop custom treatments
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Nome uses AI and drug-development expertise to help rare disease families turn genetic diagnoses into potential paths toward treatment.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC